David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Amdocs
DOX
$6.41B
| $34.8M | 0.05% |
639,120
-50,975
| -7% | -$2.57M |
|
|
POT
402
DELISTED
Potash Corp Of Saskatchewan
POT
| $34.7M | 0.05% |
1,077,440
+1,038,135
| +2,641% | +$36.5M |
|
403
Cirrus Logic
CRUS
$5.78B
| $34.7M | 0.05% |
1,044,656
+757,737
| +264% | +$22M |
|
404
Wynn Resorts
WYNN
$10.3B
| $34.7M | 0.05% |
275,424
-159,173
| -37% | -$22.7M |
|
405
PUT
Home Depot
HD
$335B
| $34.7M | 0.05% |
305,100
-435,300
| -59% | -$48M |
|
406
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
| $34.6M | 0.05% |
76,700
-105,000
| -58% | -$44.5M |
|
407
Expedia Group
EXPE
$38.6B
| $34.5M | 0.05% |
366,989
-637,919
| -63% | -$56.6M |
|
|
FDO
408
DELISTED
FAMILY DOLLAR STORES
FDO
| $34.5M | 0.05% |
435,363
-614,917
| -59% | -$48M |
|
|
ABMD
409
DELISTED
Abiomed Inc
ABMD
| $34.5M | 0.05% |
481,451
+131,113
| +37% | +$7.12M |
|
410
PUT
McKesson
MCK
$100B
| $34.4M | 0.05% |
152,200
-320,000
| -68% | -$71M |
|
|
WBA
411
DELISTED
Walgreens Boots Alliance
WBA
| $34.4M | 0.05% |
406,523
-17,346
| -4% | -$1.38M |
|
412
PUT
American Express
AXP
$227B
| $34.2M | 0.05% |
438,300
-36,500
| -8% | -$3.03M |
|
413
CALL
Gilead Sciences
GILD
$181B
| $34.1M | 0.05% |
347,100
-442,000
| -56% | -$44.9M |
|
414
PUT
Goldman Sachs
GS
$303B
| $33.8M | 0.05% |
179,900
-519,100
| -74% | -$96.6M |
|
|
NFX
415
DELISTED
Newfield Exploration
NFX
| $33.7M | 0.05% |
960,474
+168,805
| +21% | +$5.11M |
|
|
BMS
416
DELISTED
Bemis
BMS
| $33.6M | 0.05% |
725,925
+172,309
| +31% | +$8M |
|
|
VIAB
417
DELISTED
Viacom Inc. Class B
VIAB
| $33.3M | 0.05% |
488,171
-516,949
| -51% | -$35.7M |
|
418
PUT
United Parcel Service
UPS
$86.8B
| $33.2M | 0.05% |
342,800
-443,000
| -56% | -$45.5M |
|
|
CST
419
DELISTED
CST Brands, Inc.
CST
| $33.1M | 0.05% |
754,848
+144,488
| +24% | +$6.27M |
|
|
CPN
420
DELISTED
Calpine Corporation
CPN
| $33M | 0.05% |
1,445,154
-251,569
| -15% | -$5.42M |
|
421
Corning
GLW
$129B
| $33M | 0.05% |
1,455,399
+496,608
| +52% | +$11.8M |
|
422
IQVIA
IQV
$42.8B
| $32.6M | 0.05% |
486,847
+321,499
| +194% | +$20.3M |
|
|
VISN
423
Vistance Networks Inc
VISN
$2.59B
| $32.5M | 0.05% |
1,138,148
+775,206
| +214% | +$21.6M |
|
424
Goodyear
GT
$1.72B
| $32.5M | 0.05% |
1,198,983
+567,190
| +90% | +$14.8M |
|
425
Leidos
LDOS
$17.7B
| $32.4M | 0.05% |
771,134
-189,249
| -20% | -$8.23M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.